208 related articles for article (PubMed ID: 18992310)
1. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
[TBL] [Abstract][Full Text] [Related]
2. Characterization of melt extruded and conventional Isoptin formulations using Raman chemical imaging and chemometrics.
Vajna B; Pataki H; Nagy Z; Farkas I; Marosi G
Int J Pharm; 2011 Oct; 419(1-2):107-13. PubMed ID: 21803139
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
4. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting.
Lunio R; Sawicki W
Pharmazie; 2008 Oct; 63(10):731-5. PubMed ID: 18972835
[TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on the release of morphine sulfate from Oramorph SR tablets.
Barkin RL; Shirazi D; Kinzler E
Am J Ther; 2009; 16(6):482-6. PubMed ID: 19770796
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol.
Fadda HM; Mohamed MA; Basit AW
Int J Pharm; 2008 Aug; 360(1-2):171-6. PubMed ID: 18547758
[TBL] [Abstract][Full Text] [Related]
7. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
8. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
Timmins P; Delargy AM; Howard JR
Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
[TBL] [Abstract][Full Text] [Related]
9. Per-oral extended-release bioadhesive tablet formulation of verapamil HCl.
Elkheshen S; Yassin AE; Alkhaled F
Boll Chim Farm; 2003 Jun; 142(5):226-31. PubMed ID: 14526657
[TBL] [Abstract][Full Text] [Related]
10. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
Kostova B; Rachev D
Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.
Garbacz G; Golke B; Wedemeyer RS; Axell M; Söderlind E; Abrahamsson B; Weitschies W
Eur J Pharm Sci; 2009 Sep; 38(2):147-55. PubMed ID: 19591927
[TBL] [Abstract][Full Text] [Related]
12. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
13. In vitro dissolution of oral modified-release tablets and capsules in ethanolic media.
Smith AP; Moore TW; Westenberger BJ; Doub WH
Int J Pharm; 2010 Oct; 398(1-2):93-6. PubMed ID: 20667505
[TBL] [Abstract][Full Text] [Related]
14. Influence of ethanol on aspirin release from hypromellose matrices.
Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of verapamil hydrochloride microcapsules.
Mukherjee B; Mahanti B; Panda P; Mahapatra S
Am J Ther; 2005; 12(5):417-24. PubMed ID: 16148427
[TBL] [Abstract][Full Text] [Related]
16. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
[TBL] [Abstract][Full Text] [Related]
17. Utility of a sustained-release formulation for antihypertensive therapy.
Skaer TL; Sclar DA; Markowski DJ; Won JK
J Hum Hypertens; 1993 Oct; 7(5):519-22. PubMed ID: 8263896
[TBL] [Abstract][Full Text] [Related]
18. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine.
Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N
Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321
[TBL] [Abstract][Full Text] [Related]
19. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
Lee KR; Kim EJ; Seo SW; Choi HK
Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
